Green Square Capital Advisors LLC Eli Lilly & CO Transaction History

Green Square Capital Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $107,280 - $134,537	-148 Reduced 18.62%	647 $585,000
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $241,025 - $322,457	407 Added 104.9%	795 $618,000
Q4 2023 Jan 18, 2024	BUY	$525.19 - $619.13 $203,773 - $240,222	388 New	388 $226,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $331,147 - $389,784	-2,975 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $14,084 - $15,779	-133 Reduced 4.28%	2,975 $344,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $11,419 - $14,272	133 Added 4.47%	3,108 $334,000
Q2 2018 Aug 20, 2018	SELL	$75.7 - $86.88 $8,781 - $10,078	-116 Reduced 3.75%	2,975 $254,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,091	3,091 $254,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Green Square Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Green Square Capital Advisors LLC with notifications on news.